+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Induced Pluripotent Stem Cells Production Market 2024-2028

  • PDF Icon

    Report

  • 169 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5969599
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The induced pluripotent stem cells production market is forecasted to grow by USD 1841.79 million during 2023-2028, accelerating at a CAGR of 11.66% during the forecast period. The report on the induced pluripotent stem cells production market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of several chronic disorders, increasing adoption of ipscs in drug discovery and toxicity screening applications, and growing demand for ipscs for personalized medicines.

The induced pluripotent stem cells production market is segmented as below:

By End-user

  • Hospitals
  • Research institutes
  • Biotechnology companies
  • Others

By Product

  • Consumable and kits
  • Instrument
  • Services and others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in cell reprogramming techniques as one of the prime reasons driving the induced pluripotent stem cells production market growth during the next few years. Also, emergence of ipsc banks and repositories and growing applications of ipscs in regenerative medicine will lead to sizable demand in the market.

The report on the induced pluripotent stem cells production market covers the following areas:

  • Induced pluripotent stem cells production market sizing
  • Induced pluripotent stem cells production market forecast
  • Induced pluripotent stem cells production market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading induced pluripotent stem cells production market vendors that include Allele Biotechnology and Pharmaceuticals Inc., ALSTEM, Applied Biological Materials Inc., Applied StemCell, ATCC, Axol Biosciences Ltd., Becton Dickinson and Co., Bio Techne Corp., Board of Regents of the University of Wisconsin System, Creative Biolabs, Cyagen Biosciences, Cynata Therapeutics Ltd., Evotec SE, Fate Therapeutics Inc., FUJIFILM Corp., Hitachi Ltd., LIFE and BRAIN GmbH, Lonza Group Ltd., Ncardia Services B.V., REPROCELL Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the induced pluripotent stem cells production market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global induced pluripotent stem cells production market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global induced pluripotent stem cells production market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Research institutes - Market size and forecast 2023-2028
Exhibit 38: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
6.5 Biotechnology companies - Market size and forecast 2023-2028
Exhibit 42: Chart on Biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Biotechnology companies - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by End-user
Exhibit 50: Market opportunity by End-user ($ million)
Exhibit 51: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 52: Chart on Product - Market share 2023-2028 (%)
Exhibit 53: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 54: Chart on Comparison by Product
Exhibit 55: Data Table on Comparison by Product
7.3 Consumable and kits - Market size and forecast 2023-2028
Exhibit 56: Chart on Consumable and kits - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Consumable and kits - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Consumable and kits - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Consumable and kits - Year-over-year growth 2023-2028 (%)
7.4 Instrument - Market size and forecast 2023-2028
Exhibit 60: Chart on Instrument - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Instrument - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Instrument - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Instrument - Year-over-year growth 2023-2028 (%)
7.5 Services and others - Market size and forecast 2023-2028
Exhibit 64: Chart on Services and others - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Services and others - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Services and others - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Services and others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Product
Exhibit 68: Market opportunity by Product ($ million)
Exhibit 69: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Allele Biotechnology and Pharmaceuticals Inc.
Exhibit 119: Allele Biotechnology and Pharmaceuticals Inc. - Overview
Exhibit 120: Allele Biotechnology and Pharmaceuticals Inc. - Product / Service
Exhibit 121: Allele Biotechnology and Pharmaceuticals Inc. - Key offerings
12.4 Applied Biological Materials Inc.
Exhibit 122: Applied Biological Materials Inc. - Overview
Exhibit 123: Applied Biological Materials Inc. - Product / Service
Exhibit 124: Applied Biological Materials Inc. - Key offerings
12.5 Applied StemCell
Exhibit 125: Applied StemCell - Overview
Exhibit 126: Applied StemCell - Product / Service
Exhibit 127: Applied StemCell - Key offerings
12.6 ATCC
Exhibit 128: ATCC - Overview
Exhibit 129: ATCC - Product / Service
Exhibit 130: ATCC - Key offerings
12.7 Axol Biosciences Ltd.
Exhibit 131: Axol Biosciences Ltd. - Overview
Exhibit 132: Axol Biosciences Ltd. - Product / Service
Exhibit 133: Axol Biosciences Ltd. - Key offerings
12.8 Cynata Therapeutics Ltd.
Exhibit 134: Cynata Therapeutics Ltd. - Overview
Exhibit 135: Cynata Therapeutics Ltd. - Product / Service
Exhibit 136: Cynata Therapeutics Ltd. - Key offerings
12.9 Evotec SE
Exhibit 137: Evotec SE - Overview
Exhibit 138: Evotec SE - Business segments
Exhibit 139: Evotec SE - Key offerings
Exhibit 140: Evotec SE - Segment focus
12.10 Fate Therapeutics Inc.
Exhibit 141: Fate Therapeutics Inc. - Overview
Exhibit 142: Fate Therapeutics Inc. - Product / Service
Exhibit 143: Fate Therapeutics Inc. - Key offerings
12.11 FUJIFILM Corp.
Exhibit 144: FUJIFILM Corp. - Overview
Exhibit 145: FUJIFILM Corp. - Business segments
Exhibit 146: FUJIFILM Corp. - Key news
Exhibit 147: FUJIFILM Corp. - Key offerings
Exhibit 148: FUJIFILM Corp. - Segment focus
12.12 Hitachi Ltd.
Exhibit 149: Hitachi Ltd. - Overview
Exhibit 150: Hitachi Ltd. - Business segments
Exhibit 151: Hitachi Ltd. - Key news
Exhibit 152: Hitachi Ltd. - Key offerings
Exhibit 153: Hitachi Ltd. - Segment focus
12.13 LIFE and BRAIN GmbH
Exhibit 154: LIFE and BRAIN GmbH - Overview
Exhibit 155: LIFE and BRAIN GmbH - Product / Service
Exhibit 156: LIFE and BRAIN GmbH - Key offerings
12.14 Lonza Group Ltd.
Exhibit 157: Lonza Group Ltd. - Overview
Exhibit 158: Lonza Group Ltd. - Business segments
Exhibit 159: Lonza Group Ltd. - Key news
Exhibit 160: Lonza Group Ltd. - Key offerings
Exhibit 161: Lonza Group Ltd. - Segment focus
12.15 Ncardia Services B.V.
Exhibit 162: Ncardia Services B.V. - Overview
Exhibit 163: Ncardia Services B.V. - Product / Service
Exhibit 164: Ncardia Services B.V. - Key offerings
12.16 REPROCELL Inc.
Exhibit 165: REPROCELL Inc. - Overview
Exhibit 166: REPROCELL Inc. - Product / Service
Exhibit 167: REPROCELL Inc. - Key offerings
12.17 Takara Bio Inc.
Exhibit 168: Takara Bio Inc. - Overview
Exhibit 169: Takara Bio Inc. - Product / Service
Exhibit 170: Takara Bio Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global induced pluripotent stem cells production market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 50: Market opportunity by End-user ($ million)
Exhibits 51: Data Table on Market opportunity by End-user ($ million)
Exhibits 52: Chart on Product - Market share 2023-2028 (%)
Exhibits 53: Data Table on Product - Market share 2023-2028 (%)
Exhibits 54: Chart on Comparison by Product
Exhibits 55: Data Table on Comparison by Product
Exhibits 56: Chart on Consumable and kits - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Consumable and kits - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Consumable and kits - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Consumable and kits - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Instrument - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Instrument - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Instrument - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Instrument - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Services and others - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on Services and others - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on Services and others - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Services and others - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Product ($ million)
Exhibits 69: Data Table on Market opportunity by Product ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ million)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: Allele Biotechnology and Pharmaceuticals Inc. - Overview
Exhibits 120: Allele Biotechnology and Pharmaceuticals Inc. - Product / Service
Exhibits 121: Allele Biotechnology and Pharmaceuticals Inc. - Key offerings
Exhibits 122: Applied Biological Materials Inc. - Overview
Exhibits 123: Applied Biological Materials Inc. - Product / Service
Exhibits 124: Applied Biological Materials Inc. - Key offerings
Exhibits 125: Applied StemCell - Overview
Exhibits 126: Applied StemCell - Product / Service
Exhibits 127: Applied StemCell - Key offerings
Exhibits 128: ATCC - Overview
Exhibits 129: ATCC - Product / Service
Exhibits 130: ATCC - Key offerings
Exhibits 131: Axol Biosciences Ltd. - Overview
Exhibits 132: Axol Biosciences Ltd. - Product / Service
Exhibits 133: Axol Biosciences Ltd. - Key offerings
Exhibits 134: Cynata Therapeutics Ltd. - Overview
Exhibits 135: Cynata Therapeutics Ltd. - Product / Service
Exhibits 136: Cynata Therapeutics Ltd. - Key offerings
Exhibits 137: Evotec SE - Overview
Exhibits 138: Evotec SE - Business segments
Exhibits 139: Evotec SE - Key offerings
Exhibits 140: Evotec SE - Segment focus
Exhibits 141: Fate Therapeutics Inc. - Overview
Exhibits 142: Fate Therapeutics Inc. - Product / Service
Exhibits 143: Fate Therapeutics Inc. - Key offerings
Exhibits 144: FUJIFILM Corp. - Overview
Exhibits 145: FUJIFILM Corp. - Business segments
Exhibits 146: FUJIFILM Corp. - Key news
Exhibits 147: FUJIFILM Corp. - Key offerings
Exhibits 148: FUJIFILM Corp. - Segment focus
Exhibits 149: Hitachi Ltd. - Overview
Exhibits 150: Hitachi Ltd. - Business segments
Exhibits 151: Hitachi Ltd. - Key news
Exhibits 152: Hitachi Ltd. - Key offerings
Exhibits 153: Hitachi Ltd. - Segment focus
Exhibits 154: LIFE and BRAIN GmbH - Overview
Exhibits 155: LIFE and BRAIN GmbH - Product / Service
Exhibits 156: LIFE and BRAIN GmbH - Key offerings
Exhibits 157: Lonza Group Ltd. - Overview
Exhibits 158: Lonza Group Ltd. - Business segments
Exhibits 159: Lonza Group Ltd. - Key news
Exhibits 160: Lonza Group Ltd. - Key offerings
Exhibits 161: Lonza Group Ltd. - Segment focus
Exhibits 162: Ncardia Services B.V. - Overview
Exhibits 163: Ncardia Services B.V. - Product / Service
Exhibits 164: Ncardia Services B.V. - Key offerings
Exhibits 165: REPROCELL Inc. - Overview
Exhibits 166: REPROCELL Inc. - Product / Service
Exhibits 167: REPROCELL Inc. - Key offerings
Exhibits 168: Takara Bio Inc. - Overview
Exhibits 169: Takara Bio Inc. - Product / Service
Exhibits 170: Takara Bio Inc. - Key offerings
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global induced pluripotent stem cells production market: Allele Biotechnology and Pharmaceuticals Inc., ALSTEM, Applied Biological Materials Inc., Applied StemCell, ATCC, Axol Biosciences Ltd., Becton Dickinson and Co., Bio Techne Corp., Board of Regents of the University of Wisconsin System, Creative Biolabs, Cyagen Biosciences, Cynata Therapeutics Ltd., Evotec SE, Fate Therapeutics Inc., FUJIFILM Corp., Hitachi Ltd., LIFE and BRAIN GmbH, Lonza Group Ltd., Ncardia Services B.V., REPROCELL Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in cell reprogramming techniques."

According to the report, one of the major drivers for this market is the rising prevalence of several chronic disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allele Biotechnology and Pharmaceuticals Inc.
  • ALSTEM
  • Applied Biological Materials Inc.
  • Applied StemCell
  • ATCC
  • Axol Biosciences Ltd.
  • Becton Dickinson and Co.
  • Bio Techne Corp.
  • Board of Regents of the University of Wisconsin System
  • Creative Biolabs
  • Cyagen Biosciences
  • Cynata Therapeutics Ltd.
  • Evotec SE
  • Fate Therapeutics Inc.
  • FUJIFILM Corp.
  • Hitachi Ltd.
  • LIFE and BRAIN GmbH
  • Lonza Group Ltd.
  • Ncardia Services B.V.
  • REPROCELL Inc.
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.